Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 10 /hr

★★★★★

☆☆☆☆☆

Hire {0}. {1}

Egypt

USD 10 /hr

Freelance scientific writer in the field of Cancer. Highly experienced in writing research articles and reviews on cance

Profile Summary

I am an associate professor of biochemistry and cancer biology. I am very familiar with the literature and cutting-edge research in the area of cancer and metabolism, in particular the Warburg effect. I recently published many articles in high impact factor journals, which attests to the quality of the content. I am very motivated, and I like writing very much. I will therefore be pleased to take this opportunity and participate in an online journal. I was awarded the best Ph.D. award Paris 12 University where I carried out my Ph.D. In the time being, I am writing a review on Warburg effect and neurovegetative and psychiatric diseases.

Subject Matter Expertise

• ☆ Molecular Biology
• ☆ Women's Health
• ☆ Breast Cancer
• ☆ Men's Health
• ☆ Prostate Cancer
• ☆ Cancer Research
• ☆ Cancer Biology
• ☆ Carcinogenesis

Services

• Writing

Writing Technical Writing

Work Experience

Associate Professor of Biochemistry & Cancer Biology

MSA University

February 2015 - Present

Education

Ph.D.

Ph.D. Molecular and Cellular Biology

September 1989 - November 1997

Certifications

• PGCert

  Greenwich University

  November 2018 - Present

Publications

JOURNAL ARTICLE

(2021). Upregulation of leukemia-induced non-coding activator RNA (LUNAR1) predicts poor outcome in pediatric T-acute lymphoblastic leukemia . Immunobiology.

(2021). Strigol1/albumin/chitosan nanoparticles decrease cell viability, induce apoptosis and alter metabolomics profile in HepG2 cancer cell line . Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

(2020). Green <i>Coffea arabica</i> Extract Ameliorates Testicular Injury in High-Fat Diet/Streptozotocin-Induced Diabetes in Rats . Journal of diabetes research.

Bakkar, A., Alshalalfa, M., Petersen, L.F., Abou-Ouf, H., Al-Mami, A., Hegazy, S.A., Feng, F., Alhajj, R., Bijian, K., Alaoui-Jamali, M.A., et al.(2016). microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients . Molecular Biology Reports. 43. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 229-240.

Bismar, T.A., Alshalalfa, M., Petersen, L.F., Teng, L.H., Gerke, T., Bakkar, A., Al-Mami, A., Liu, S., Dolph, M., Mucci, L.A., et al.(2014). Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcome . BJU International. 113. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 309-319.

Petersen, L.F., Brockton, N.T., Bakkar, A., Liu, S., Wen, J., Weljie, A.M., Bismar, T.A.(2012). Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells . BJU International. 109. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 788-795.

Neuzillet, Y., Paoletti, X., Ouerhani, S., Mongiat-Artus, P., Soliman, H., de The, H., Sibony, M., Denoux, Y., Molinie, V., Herault, A., et al.(2012). A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer . PLoS ONE. 7. (12).

Benitez, A., Yates, T.J., Lopez, L.E., Cerwinka, W.H., Bakkar, A., Lokeshwar, V.B.(2011). Targeting hyaluronidase for cancer therapy: Antitumor activity of sulfated hyaluronic acid in prostate cancer cells . Cancer Research. 71. (12). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 4085-4095.

Bakkar, A.A., Allory, Y., Iwatsubo, Y., De Medina, S.G.D., Maille, P., Khreich, N., Riou, A., Leroy, K., Vordos, D., Abbou, C.C., et al.(2010). Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinoma . Molecular Carcinogenesis. 49. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 25-31.

Nicolle, G., Daher, A., Maill&#233;, P., Vermey, M., Loric, S., Bakkar, A., Wallerand, H., Vordos, D., Vacherot, F., De Medina, S.G.D., et al.(2006). Gefitinib inhibits the growth and invasion of urothelial carcinoma cell lines in which Akt and MARK activation is dependent on constitutive epidermal growth factor receptor activation . Clinical Cancer Research. 12. (9). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2937-2943.

Wallerand, H., Bakkar, A.A., de Medina, S.G.D., Pairon, J.-C., Yang, Y.-C., Vordos, D., Bittard, H., Fauconnet, S., Kouyoumdjian, J.-C., Jaurand, M.-C., et al.(2005). Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: Contribution of exogenous versus endogenous carcinogens . Carcinogenesis. 26. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 177-184.

Bakkar, A.A., Quach, V., Le Borgne, A., Toublanc, M., Henin, D., Wallerand, H., Radvanyi, F., Bittard, H., Ravery, V., Gibod, L.B., et al.(2005). Sensitive allele-specific PCR assay able to detect FGFR3 mutations in tumors and urine from patients with urothelial cell carcinoma of the bladder . Clinical Chemistry. 51. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1555-1557.

Bakkar, A.A., Wallerand, H., Radvanyi, F., Lahaye, J.-B., Pissard, S., Lecerf, L., Kouyoumdjian, J.C., Abbou, C.C., Pairon, J.-C., Jaurand, M.-C., et al.(2003). FGFR3 and TP53 Gene Mutations Define Two Distinct Pathways in Urothelial Cell Carcinoma of the Bladder . Cancer Research. 63. (23). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 8108-8112.